MADIT-CRT Trial Results Provide Clinical Evidence That Cardiac Resynchronization Therapy Significantly Slows Heart Failure Progression

Natick, MA and Barcelona (September 1, 2009) — Boston Scientific Corporation (NYSE: BSX) today announced final results from the landmark MADIT-CRT trial, which were published by the New England Journal of Medicine and presented during a Hot Line session at the annual European Society of Cardiology (ESC) Congress in Barcelona.More on the MADIT-CRT Heart Failure Trials Results

NewsInfusion | September 1, 2009

Tags:. .presented. .natick. .crt. .nyse. .cardiology